TESORO SUB-Q WITH LIDOCAINE 1.0ML

Tesoro Sub-Q with Lidocaine

Tesoro Sub-Q with Lidocaine is a cross-linked hyaluronic acid (HA) dermal filler from BNC Global (now BNCERA), South Korea. It is the second-firmest gel in the Tesoro range, between Deep and Implant, and is designed for deep subdermal injection to restore volume in the cheeks and chin and to correct deep nasolabial folds and deep wrinkles. It contains 20 mg/ml cross-linked HA and 0.3% lidocaine to improve comfort during injection. Each box contains one 1.0 ml pre-filled syringe and two needles (25G and 27G). For use by licensed physicians only.

Key Features

• Firm Volumising Gel: Cross-linking level 4 of 5 in the Tesoro range, firmer than Deep and softer than Implant.
• HA 20 mg/ml: Cross-linked hyaluronic acid, produced with a three-step cross-linking process according to the manufacturer.
• With 0.3% Lidocaine: Helps reduce discomfort during injection. A version without lidocaine is also available.
• Two Needle Sizes: Supplied with one 25G and one 27G thin-wall needle.
• Reversible: Hyaluronic acid can be dissolved with hyaluronidase by a qualified practitioner.

The Tesoro Range

The Tesoro range includes four gels of increasing cross-linking level. Fine, Deep and Sub-Q are available with or without lidocaine. Implant is available with lidocaine only. The physician selects the product according to the treatment area and tissue depth.

• Tesoro Fine: HA 20 mg/ml. The softest gel, for fine lines, injected intradermally.
• Tesoro Deep: HA 20 mg/ml. For moderate wrinkles and folds, injected subdermally.
• Tesoro Sub-Q: HA 20 mg/ml. For deep wrinkles and facial volume, injected deep subdermally.
• Tesoro Implant: HA 24 mg/ml. The firmest gel, for facial contour, injected deep subdermally.

Intended Use

• Cheek and cheekbone (zygomatic) volume
• Chin volume
• Deep nasolabial folds
• Deep wrinkles and folds

Treatment area, injection depth, technique and volume must follow the official Instructions for Use and the treating physician’s assessment. Results and duration vary between individuals.

Product Specifications

• Brand: Tesoro
• Product: Tesoro Sub-Q with Lidocaine
• Company: BNC Global (now BNCERA)
• Origin: South Korea
• Composition: Cross-linked hyaluronic acid 20 mg/ml, lidocaine hydrochloride 3 mg/ml (0.3%)
• Injection Depth: Deep subdermal
• Needles: 1 × 25G TW, 1 × 27G TW
• Contents: 1 × 1.0 ml pre-filled syringe, 2 needles
• Shelf Life: 24 months from date of manufacture. Refer to the carton for the expiry date.
• Product Type: Hyaluronic acid dermal filler (medical device)

Administration

• For use only by licensed physicians trained in facial anatomy, filler injection techniques and the management of filler complications.
• Check that the packaging is intact and the product is within its expiry date before use.
• Inject under aseptic conditions at the depth specified in the IFU. Inject slowly in small amounts.
• Not intended for superficial lines or the lips. Other gels in the range are designed for those uses.
• Confirm the patient has no allergy to lidocaine or other amide-type local anaesthetics before use.
• Injection technique, volume and treatment interval must follow the IFU and the treating physician’s judgment.
• Do not self-administer.

Contraindications

According to the manufacturer, this product should not be used in:

• Persons under 18 years of age
• Persons with known intolerance to any component of the product
• Pregnancy or breastfeeding
• Autoimmune diseases
• Diabetes
• Acute infections or colds
• Epilepsy
• Open ulcers, wounds or damaged skin at the planned injection site

Who Should Consult a Physician First

• People with known allergy to lidocaine or other amide-type local anaesthetics
• People with bleeding disorders or taking anticoagulant or antiplatelet medication
• People with a tendency to hypertrophic scars or keloids, or severe allergies
• People with heart rhythm disorders, severe liver disease or porphyria
• People with permanent fillers or implants in the treatment area

Precautions

• Common reactions include redness, swelling, pain, tenderness, itching and bruising at the injection site.
• Lumps, nodules, asymmetry, product migration, infection and delayed inflammatory reactions may occur.
• Accidental injection into a blood vessel can cause vascular occlusion, skin necrosis and, rarely, visual impairment or blindness. The nasolabial fold, cheek and chin are areas with significant vascular risk.
• The total lidocaine dose should be considered when combined with other local anaesthetics.
• Hyaluronic acid can be dissolved with hyaluronidase. Practitioners should keep hyaluronidase and an emergency protocol available.
• Seek medical attention immediately for severe or increasing pain, skin blanching or colour change, or any change in vision after treatment.
• Do not use if the packaging is open or damaged, the syringe is cracked or the product is past its expiry date.
• Single use only. One syringe, one patient. Do not re-sterilise. Keep out of reach of children.

After Treatment

The manufacturer advises avoiding strenuous exercise and exposure to extreme temperatures for 24 hours after treatment. Follow the aftercare instructions given by the treating physician and report any adverse reaction.

Storage

Store at room temperature (2–25°C). Protect from direct sunlight and freezing. Refer to the carton for the expiry date.

Package Contents

• 1 × 1.0 ml pre-filled syringe of Tesoro Sub-Q with Lidocaine
• 1 × 25G TW needle, 1 × 27G TW needle
• Instructions for Use

Important Notice

For professional healthcare use only. This information is for general product reference. It does not replace medical advice, the official Instructions for Use or local regulations. This product is not intended to diagnose, treat, cure or prevent any disease. Results vary between individuals.